e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular biomarkers for lung adenocarcinoma
Olivier Calvayrac, Anne Pradines, Elvire Pons, Julien Mazières, Nicolas Guibert
Source:
Eur Respir J , 49 (4) 1601734; DOI: 10.1183/13993003.01734-2016
Journal Issue:
April
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Olivier Calvayrac, Anne Pradines, Elvire Pons, Julien Mazières, Nicolas Guibert. Molecular biomarkers for lung adenocarcinoma. Eur Respir J , 49 (4) 1601734; DOI: 10.1183/13993003.01734-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Molecular abnormalities and histopathology in lung cancer
Source: ERS Research Seminar
Year: 2015
Molecular markers in non-small cell lung carcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Molecular imprint of lung cancer development
Source: ERS Lung Science Conference 2017
Year: 2017
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Molecular hallmarks of smoking in the Gauting lung adenocarcinoma donors
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Molecular biologic characterization of operated non-small cell lung cancer according to smoking history
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008
Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Metabolomics in lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017
Molecular and clinical profile of adenocarcinoma lung among Indian women
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
Validation of diagnostic molecular markers in bronchial fluid for lung cancer
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011
Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006
Identification of tumor-associate proteins in stage-I lung squamous cancer by proteomics
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Multi-omic molecular profiling of lung cancer in COPD
Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept